Topics

vaccine biodistribution

A method of tracking where compounds of interest travel and where they are retained in the organs and tissues of an experimental animal or human subject receiving a vaccine; the biodistribution of a vaccine.

vaccines
‘Spikeopathy’: COVID-19 Spike Protein Is Pathogenic, from Both Virus and Vaccine mRNA
2.4 Nonclinical Overview AZD1222
Adverse effects of COVID-19 mRNA vaccines: the spike hypothesis
Assessment report: COVID-19 Vaccine Moderna
Autoimmune inflammatory reactions triggered by the COVID-19 genetic vaccines in terminally differentiated tissues
Barrier Capacity of Human Placenta for Nanosized Materials
Biodistribution of mRNA COVID-19 vaccines in human breast milk
Challenges and Opportunities of mRNA Vaccines Against SARS-CoV-2 - A Multidisciplinary Perspective
COVID Vaccine Autopsy Reports: Shocking Impact Revealed
COVID-19 vaccines – An Australian Review
Current state of knowledge on the excretion of mRNA and spike produced by anti-COVID-19 mRNA vaccines; possibility of contamination of the entourage of those vaccinated by these products
Detection of antibodies to SARS-CoV-2 after vaccination in seminal plasma and their association to sperm parameters
Differences in Vaccine and SARS-CoV-2 Replication Derived mRNA: Implications for Cell Biology and Future Disease
Dispelling the Myth of a Pandemic of the Unvaccinated
Duration of SARS-CoV-2 mRNA vaccine persistence and factors associated with cardiac involvement in recently vaccinated patients
Existing and emerging mRNA vaccines and their environmental impact: a transdisciplinary assessment
Expression of SARS-CoV-2 spike protein in cerebral Arteries: Implications for hemorrhagic stroke Post-mRNA vaccination
First case of postmortem study in a patient vaccinated against SARS-CoV-2
For “Such a Time as This”
Immunohistologic Features of Cerebral Venous Thrombosis Due to Vaccine-Induced Immune Thrombotic Thrombocytopenia
Inadvertent Exposure to Pharmacologically Designed Lipid Nanoparticles Via Bodily Fluids: Biologic Plausibility and Potential Consequences
Interview: Dr. Byram Bridle Professor of Viral Immunology on Spike Protein
mRNA "vaccine" biodistribution, persistence, and adjuvant toxicity library
Nanocarrier imaging at single-cell resolution across entire mouse bodies with deep learning
Nonclinical Evaluation Report: BNT162b2 [mRNA] COVID-19 vaccine (COMIRNATY)
Pfizer/BioNTech’s COVID-19 modRNA Vaccines: Dangerous Genetic Mechanism of Action Released before Sufficient Preclinical Testing
Potential adverse effects of nanoparticles on the reproductive system
Potential Conscientious Objection to mRNA Technology as Preventive Treatment for COVID-19
Potential health risks of mRNA-based vaccine therapy: A hypothesis
Rapid Response to: Will covid-19 vaccines save lives? Current trials aren’t designed to tell us
Research Letter: Detection of Messenger RNA COVID-19 Vaccines in Human Breast Milk
Safe Nanoparticles: Are We There Yet?
SARS-CoV-2 and the Vaccination Hype
SARS-COV-2 mRNA Vaccine (BNT162, PF-07302048) — 2.6.4 Summary statement of the pharmacokinetic study
SARS-CoV-2 Spike Protein Accumulation in the Skull-Meninges-Brain Axis: Potential Implications for Long-Term Neurological Complications in post-COVID-19
Scientific Lay Summary to Support the Letter of Concern to Prime Ministers and Governing Bodies
Spike Proteins of SARS-CoV-2 Induce Pathological Changes in Molecular Delivery and Metabolic Function in the Brain Endothelial Cells
Statement by Dr. Richard Urso
Strategies for the Management of Spike Protein-Related Pathology
The COVID-19 “Vaccines”: What is the truth?
The mRNA-LNP vaccines – the good, the bad and the ugly?
The Pfizer mRNA vaccine is contaminated with the plasmid DNA vector that was used as the template for in vitro transcription reaction.
The Pfizer Papers: Pfizer's Crimes Against Humanity
The SARS-CoV-2 spike protein alters barrier function in 2D static and 3D microfluidic in-vitro models of the human blood–brain barrier
Understanding the Pharmacology of COVID-19 mRNA Vaccines: Playing Dice with the Spike?
Urgent Open Letter from Doctors and Scientists to the European Medicines Agency regarding COVID-19 Vaccine Safety Concerns
Vaccine mRNA Can Be Detected in Blood at 15 Days Post-Vaccination
551